$86.40
-1.87-2.12%
al cierre: Sep 9, 5:00 PM EST
$86.50
0.10.12%
After hour: 4:11 PM EST
TransMedics Group Inc
TMDXNASDAQ
TransMedics Group Earnings & Forecasts
TransMedics Group (TMDX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
TransMedics Group Guidance
TransMedics Group (TMDX) publicó su última previsión de agosto 4, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $737M - $757M para el período.
En comparación con la previsión anterior, TransMedics Group mantenido redujo su previsión de ingresos desde un rango anterior de $727M - $757M.
TransMedics Group ha emitido 17 actualizaciones de orientación entre el noviembre 3, 2022 y el agosto 4, 2026. During this period, the company raised its outlook 11 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.52 | $0.61 | $0.39 | $0.36 |
| Actual | $0.44 | $0.30 | $0.57 | $0.66 |
| Surprise | -15.4% | -50.8% | +46.2% | +83.3% |
| Revenue | ||||
| Estimate | $184.1M | $174.4M | $155.3M | $144.8M |
| Actual | $189.9M | $173.9M | $160.8M | $143.8M |
| Surprise | +3.20% | -0.26% | +3.50% | -0.69% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.29 | $0.50 | $0.55 | $0.63 |
| Revenue | ||||
| Consensus | $177.6M | $201.0M | — | — |